Kevin Parker is the CEO and co-founder of Cartography Biosciences. Kevin completed his PhD at Stanford working in the interface of genomics, immunology, and computational biology. He holds a B.A. in Human Developmental and Regenerative Biology from Harvard University. Kevin has co-authored papers in journals such as Cell and Science directed at understanding immunotherapy responses, analyzing antigen profiles, and developing novel single-cell genomics methodologies. At Cartography, he is motivated to improve patient outcomes and bring new therapies to patients, and outside of Cartography, Kevin is an avid rock climber.